-
Mashup Score: 11Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma - PubMed - 1 year(s) ago
Both RFA and SBRT are effective local treatment options for inoperable HCC. Although these data are retrospective, SBRT appears to be a reasonable first-line treatment of inoperable, larger HCC.
Source: pubmed.ncbi.nlm.nih.govCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 9
Original Article from The New England Journal of Medicine ā BRAFāMEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas
Source: www.nejm.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Kudos to authors. Unclear role for most craniopharyngiomas w/ this drug combo. Recent @NEJM paper on craniopharyngioma with BRAF-MEK inh: https://t.co/XTZtp6QyA7 Just take a momment to compare this to a much larger phase 2 trial of protons/photons. @ASTRO_org @nytimes https://t.co/AY39nWUOA0
-
-
Mashup Score: 0Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials - PubMed - 1 year(s) ago
Prostate cancer is the most frequent cancer in men and a leading cause of cancer death. Determining a patient’s optimal therapy is a challenge, where oncologists must select a therapy with the highest likelihood of success and the lowest likelihood of toxicity. International standards for prognostic ā¦
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
@AmarUKishan @NRGonc @EORTC @NCCN @alison_tree @rtdess @HimanshuNagarMD @DrHowardSandler @ASCO @JCO_ASCO 10/n Those interested in the methods of 1st model we made by @AndreEsteva et al with @arteraAI , @NRGonc checkout https://t.co/p6RnUot0X5 that was a prognostic model. https://t.co/RxiNtRMTqB
-
-
Mashup Score: 4Please wait whilst we redirect you - 1 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright Ā© 2023 Elsevier B.V. or its licensors or contributors. ScienceDirectĀ® is a registered trademark of Elsevier B.V.ScienceDirectĀ® is a registered trademark…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @RadioOncologia: Link to the full study file. https://t.co/KRQG7yzLOC Congrats @gusviani @fabiomoraesmd @DrSpratticus @DrAlexLouie httpsā¦
-
-
Mashup Score: 9
A large āde-escalationā trial suggests that tens of thousands of people annually may be able to rely on only chemotherapy and surgery to treat their illness.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Rectal Cancer Patients May Not Need Radiation, Study Finds - The New York Times ā¦@nytimesā© feel free to DM me. As Chair of large Radiation Onc Department I would be happy to inform you of danger of the article for pts. Easy fix. Worth it to fix. https://t.co/t1qrOVkHue
-
-
Mashup Score: 4Mail View - 2 year(s) ago
Unable to process request ā the mailing requested is invalid or no longer available.
Source: mailview.bulletinhealthcare.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Come on #ASCO! How many NCDB/SEER studies are you going to promote about surgery > RT improves OS. Especially in lung cancer where primary indication for SBRT is pt not being healthy enough to have surgery. Can we get some QC for ASCO at least? https://t.co/86D6t9JAYk
-
-
Mashup Score: 1Purpose with Pure Intent | Dan Spratt, MD - 2 year(s) ago
July 22, 2021Presented by: Case Comprehensive Cancer CenterDaniel E. Spratt, MD, the Vincent K. Smith Chair in Radiation Oncology at Seidman Cancer Center, U…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
One of the talks I am very proud of. A highly personal talk on my life that I hope can help someone get onto the path they want. ā¦Lessons from my bros (ā¦@SamSpratt, Ben, and Avi), parents, wife, leaders likeā© ā¦ā¦@simonsinek https://t.co/VM0niyEfbE
-
-
Mashup Score: 6Men with advanced prostate cancer 'missing months of therapy' amid medication shortage | CNN - 2 year(s) ago
Doctors across the United States who treat people with advanced prostate cancer can’t find supplies of a medicine that may help them live longer.
Source: CNNCategories: Latest Headlines, UrologyTweet-
Honored to represent @RadoncUh and Seidman Cancer Center and our incredible GU team @CNN interview. https://t.co/FQD6fbDdko I know I speak for many to the impact of Pluvicto shortage and Novartis working hard to get things running. @Novartis @US_FDA @DanSimonMD @TedTeknosMD https://t.co/PYPVfiFY8A
-
-
Mashup Score: 2
Purpose Focal therapy (FT) for localized prostate cancer (PCa) is only recommended within the context of clinical trials by international guidelines. We aimed to investigate oncological follow-up and safety data of focal high-intensity focused ultrasound (HIFU) treatment. Methods We conducted a single-center prospective study of 29 patients with PCa treated with (focal) HIFU between 2016 and…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @5_utr: Phase 2 HIFU for prostate cancer: 2-year failure rate after HIFU: 38% ā ļø āļø š https://t.co/fskAWEBmUp
-
-
Mashup Score: 0Neil Degrasse Tyson - 2 year(s) agoSource: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet
-
Provocative and makes you thinkā¦ https://t.co/exA0fzAwkJ
-
Only 1 talk for 20 min for discussion of RT for liver cancer! What about great data on adaptive, MR guided, and even protons. Ask for more time š After all, Michigan showed SBRT superior to other ablation methods for HCC š https://t.co/60yRZe0Pee https://t.co/Xpxe6ObohL